BG105583A - Thiourea as inhibitor of herpes viruses - Google Patents

Thiourea as inhibitor of herpes viruses

Info

Publication number
BG105583A
BG105583A BG105583A BG10558301A BG105583A BG 105583 A BG105583 A BG 105583A BG 105583 A BG105583 A BG 105583A BG 10558301 A BG10558301 A BG 10558301A BG 105583 A BG105583 A BG 105583A
Authority
BG
Bulgaria
Prior art keywords
carbon atoms
alkyl
atoms
hydrogen
perhaloalkyl
Prior art date
Application number
BG105583A
Other languages
Bulgarian (bg)
English (en)
Inventor
Jonathan BLOOM
Kevin CURRAN
Martin DIGRANDI
Russell DUSHIN
Stanley Lang
Emily NORTON
Adma ROSS
Bryan O'HARA
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Publication of BG105583A publication Critical patent/BG105583A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/22Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
BG105583A 1998-12-09 2001-06-08 Thiourea as inhibitor of herpes viruses BG105583A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20856198A 1998-12-09 1998-12-09
PCT/US1999/028837 WO2000034238A1 (en) 1998-12-09 1999-12-06 Thiourea inhibitors of herpes viruses

Publications (1)

Publication Number Publication Date
BG105583A true BG105583A (en) 2001-12-29

Family

ID=22775050

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105583A BG105583A (en) 1998-12-09 2001-06-08 Thiourea as inhibitor of herpes viruses

Country Status (26)

Country Link
EP (1) EP1137632B1 (pt)
JP (1) JP2002531545A (pt)
KR (1) KR20010089559A (pt)
CN (1) CN1332725A (pt)
AR (1) AR033789A1 (pt)
AT (1) ATE272052T1 (pt)
AU (1) AU1934500A (pt)
BG (1) BG105583A (pt)
BR (1) BR9916086A (pt)
CA (1) CA2351403A1 (pt)
CZ (1) CZ20011957A3 (pt)
DE (1) DE69919023T2 (pt)
DK (1) DK1137632T3 (pt)
EA (1) EA200100634A1 (pt)
ES (1) ES2224733T3 (pt)
HU (1) HUP0104763A3 (pt)
ID (1) ID30287A (pt)
IL (1) IL143262A0 (pt)
NO (1) NO20012838L (pt)
NZ (1) NZ512108A (pt)
PL (1) PL348178A1 (pt)
PT (1) PT1137632E (pt)
SK (1) SK7702001A3 (pt)
TR (1) TR200101597T2 (pt)
WO (1) WO2000034238A1 (pt)
ZA (1) ZA200104144B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
DK1259485T3 (da) 2000-02-29 2006-04-10 Millennium Pharm Inc Benzamider og beslægtede inhibitorer for faktor Xa
DE10217518A1 (de) * 2002-04-19 2003-11-06 Bayer Ag Lactone
DE10222024A1 (de) * 2002-05-17 2003-11-27 Bayer Ag Lactame
DE10257786A1 (de) * 2002-12-11 2004-07-01 Bayer Healthcare Ag Oxazolidinone
PT2077995E (pt) 2006-11-02 2012-05-10 Millennium Pharm Inc Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa
EP2714941A4 (en) * 2011-05-24 2014-12-03 Wistar Inst COMPOSITIONS AND METHODS FOR MODULATING THE EFFECT OF THE EPSTEIN-BARR NUCLEAR ANTIGEN 1
WO2014070978A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
WO2014070979A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
WO2022150962A1 (en) * 2021-01-12 2022-07-21 Westlake Pharmaceutical (Hangzhou) Co., Ltd. Protease inhibitors, preparation, and uses thereof
AU2022343340A1 (en) * 2021-09-07 2024-03-28 Qilu Animal Health Products Co., Ltd. 3clpro protease inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210683B (en) * 1990-06-18 1995-06-28 Sandoz Ag Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
WO1996025157A1 (en) * 1995-02-17 1996-08-22 Smithkline Beecham Corporation Il-8 receptor antagonists
GB9519270D0 (en) * 1995-09-21 1995-11-22 Sandoz Pharma Uk Organic compounds
CN1515248A (zh) * 1996-04-23 2004-07-28 ��̩��˹ҩ��ɷ����޹�˾ 用作肌苷-5'-一磷酸脱氢酶抑制剂的脲衍生物

Also Published As

Publication number Publication date
AU1934500A (en) 2000-06-26
WO2000034238A1 (en) 2000-06-15
NZ512108A (en) 2003-09-26
BR9916086A (pt) 2001-09-04
HUP0104763A2 (hu) 2002-04-29
CA2351403A1 (en) 2000-06-15
HUP0104763A3 (en) 2005-04-28
TR200101597T2 (tr) 2001-10-22
ES2224733T3 (es) 2005-03-01
PL348178A1 (en) 2002-05-06
DK1137632T3 (da) 2004-11-01
EP1137632A1 (en) 2001-10-04
SK7702001A3 (en) 2002-04-04
EP1137632B1 (en) 2004-07-28
ID30287A (id) 2001-11-15
JP2002531545A (ja) 2002-09-24
ZA200104144B (en) 2002-08-21
KR20010089559A (ko) 2001-10-06
EA200100634A1 (ru) 2001-10-22
NO20012838L (no) 2001-08-08
ATE272052T1 (de) 2004-08-15
CN1332725A (zh) 2002-01-23
DE69919023T2 (de) 2005-07-28
CZ20011957A3 (cs) 2001-10-17
AR033789A1 (es) 2004-01-07
NO20012838D0 (no) 2001-06-08
DE69919023D1 (de) 2004-09-02
PT1137632E (pt) 2004-11-30
IL143262A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
BG105583A (en) Thiourea as inhibitor of herpes viruses
WO2000034237A3 (en) Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
NO177704C (no) Analogifremgangsmåte ved fremstilling av guanidiner
NZ503910A (en) Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
WO2000034260A3 (en) Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
BG105581A (en) Heterocyclic carboxamide-containing thiurea inhibitor of herpes viruses containing phenylenediamine group
PL308343A1 (en) Novel bicyclic aromatic compounds, pharmaceutic and cosmetic compositions containing such compounds and method of using them
HUP0203405A2 (hu) Szubsztituált fenilén-diamin-csoportot és heterociklikus karboxamidcsoportot hordozó herpeszvírus inhibitor hatású tiokarbamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP9902992A3 (en) Alpha-amino acid amides, preparation thereof and pharmaceutical compositions containing them
NO20012836L (no) Tiourea-inhibitorer for herpes virus
IL69659A (en) 6-(2-(cyclic amino)ethylamino)tetrahydrotriazolo(3,4-a)phthalazines,their preparation and pharmaceutical compositions containing them
GR3006939T3 (pt)
DE3465085D1 (en) Derivatives of 4-(3-alkynyloxy-2-hydroxy-propyl)-piperazin-1-yl-n-phenyl acetamide, their preparation and their therapeutical use
NO20012837L (no) Tiourea-inhibitorer for herpesvirus
DE69808326D1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
EP1120415A4 (en) SUBSTITUTED ISOXAZOLYLTHIOPHENE COMPOUNDS
ATE25514T1 (de) Biscyclohexylaminalkane und verfahren zur bekaempfung von pilzen.
DK398189A (da) 2-amino-4-morpholino-6-propyl-1,3,5-triaziner og farmaceutiske praeparater med indhold af saadanne forbindelser
FR2472567B1 (pt)
ATE31404T1 (de) Verfahren zur herstellung von cycklopropanabkoemmlingen.
RU99106583A (ru) Бидентатные ингибиторы металлопротеаз